期刊文献+

C-erbB-2、p53和PCNA对乳腺浸润性癌预后价值的Cox回归分析 被引量:4

The prognostic value of c-erbB-2,p53 and PCNA by Cox regression analysis in invasive breast carcinoma
下载PDF
导出
摘要 目的探讨癌基因。c-erbB-2产物、抑癌基因p53突变型蛋白的过度表达以及增殖细胞核抗原标记指数(PCNA-LI)与乳腺浸润性癌临床病理指标的联系及其预后价值。方法随机收集79例临床随访资料齐备的病人,用免疫组化ABC法检测其c-erbB-2、p53和PCNA的表达情况,用Cox回归分析其预后意义。结果c-erbB-2和p53过度表达的阳性率分别为31.7%和48.1%。PCAN-LI中位数为17.6%。c-erbB-2与p53过度表达之间以及其与PCNA-LI、肿瘤大小、组织学分级、腋淋巴结状态等指标间均无明确的相互关联。PCNA-LI与组织学分级呈正相关,但高PCNA-LI与不良预后无明显关联。Cox回归分析显示,腋淋巴结、c-erbB-2和p53过度表达等3项指标反映不良预后,危险度分别是3.306、1.4196、1.4984。结论c-erbB-2和p53过度表达是两项危险度仅次于腋淋巴结状态的反映乳腺浸润性癌不良预后的指标,PCNA-LI无预后价值。 Objective To investigate the prognostic importance of p53, c-erbB-2 and PCNA in patients with invasive breast carcinoma. Methods Tissue Samples from 79 cases of breast cancer with full follow-up data were collected. Expression o f PCNA,overexpression of c-erbB-2 and mutant p53 protein was evaluated by immunohistochemistry in formalin-fixed paraffin-embedded tissues. The three new indicators and other more traditional clinicopathological parameters were analyzed by Cox regression model. Results of the 79 breast cancer specimens, 31. 7 % were c-erbB-2 positive and 48. 1 % were p53 positive. No significant association was found among the overexpression of c-erbB-2 and mutant p53,age at diagnosis, menopause, tumor size, histological grade, axillary lymph node involvement and PCNA labeling index(PCNA-LI). The median of PCNA-LI was 17. 6%. PCNA-LI was positively correlated to histological grade. In both monovariate Kaplan-Meier plot and multivariate Cox regression analysis,involvement of axillary lymph node,overexpression of c-erbB-2 and mutant p53, but not PCNA-LI, showed a positive correlation with shorter overall survival time. The hazard ratios of axillary lymph node involvement,overexpression of c-erbB-2 and p53 were 3. 306, 1. 4196, 1. 4984 respectively. Conclusion overexpression of c-erbB-2 and mutant p53 could be two useful indicators for poor prognosis in invasive breast carcinoma. PCNA-LI didn't showed significant prognositic value.
出处 《实用肿瘤杂志》 CAS 北大核心 2000年第6期377-381,共5页 Journal of Practical Oncology
关键词 乳腺肿瘤/病理学 预后 基因 抑制 肿瘤 基因 p53 原癌基因蛋白质c-erbB-2 增殖细胞核抗原 COX回归分析 breast neoplasms/pathology prognosis genes,suppressor,tumor genes,p53 oncogene protein c-erbB-2 PCNA Cox regression analysis
  • 相关文献

参考文献4

  • 1许良中主编..乳腺病理学[M],1999:401.
  • 2许良中,乳腺病理学,1999年,332页 被引量:1
  • 3Dahiya R,Breast Cancer Res Treat,1998年,52卷,1/3期,185页 被引量:1
  • 4Chu J S,Cancer lett,1998年,131卷,2期,145页 被引量:1

同被引文献29

  • 1李宝江,朱志华,王军业,侯景辉,赵进明,张蓬原,姚广裕,王曦,龙浩,杨名添,戎铁.Ki67、P53、VEGF和C-erbB-2在乳腺癌组织中表达的相关性研究及其临床意义[J].癌症,2004,23(10):1176-1179. 被引量:126
  • 2张丽华,侯振江.p53基因在肺癌研究中的进展[J].临床肺科杂志,2006,11(1):59-60. 被引量:18
  • 3马代远,王仁生.C-erbB-2在乳腺癌中的表达及与转移的关系[J].现代肿瘤医学,2006,14(8):1026-1027. 被引量:4
  • 4Gerdes J, Schwab U, Lemke H, et al. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation [J].Int J Cancer,1983,31(1):13-20. 被引量:1
  • 5Niewiadomska H, Jeziorski A, Borski OB. The expression of the proliferating antigen ki-67, PCNA and products of supppessor gene p53 in primary inrasire ductal breast carcinoma [J].EXP Clin Cancer Res, 1998,17 (4) : 503-510. 被引量:1
  • 6Helton ES, Chen X. p53 modulation of the DNA damage response [J]. J Cell Biochem, 2007, 100 (4):883--896. 被引量:1
  • 7Stiewe T. The p53 family in differentiation and tumorigenesis [J]. Nat Rev Cancer, 2007,7 (3) : 165 -- 168. 被引量:1
  • 8Sherr CJ,McCormiek F. The RB and p53 pathways in cancer [J]. Cancer Cell ,2002,2(2) : 103--112. 被引量:1
  • 9Laptenko O, Prives C. Transcriptional regulation by p53: one protein, many possibilities[J].Cell Death Differ,2006, 13(6) : 951-- 961. 被引量:1
  • 10Liu CH, Chang SH, Narko k, et al. Overexpression of cyclooxygenase-2 is sufiqcient to induce tumorigenesis in transgenic mice [J]. Biol Chem,2001,276 (21) : 18563 - 18569. 被引量:1

引证文献4

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部